Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.: Anticholinergics and cognitive dysfunction

Abstract : BACKGROUND: Despite the high intake of medications with anticholinergic properties by community-dwelling elderly persons, the effects on cognitive decline and dementia have rarely been evaluated. METHODS: Participants were 4128 women and 2784 men 65 years or older from a population-based cohort recruited from 3 French cities. Cognitive performance, clinical diagnosis of dementia, and anticholinergic use were evaluated at baseline and 2 and 4 years later. RESULTS: A total of 7.5% of the participants reported anticholinergic drug use at baseline. Multivariate-adjusted logistic regression indicated that women reporting use of anticholinergic drugs at baseline showed greater decline over 4 years in verbal fluency scores (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.11-1.79) and in global cognitive functioning (OR, 1.22; 95% CI, 0.96-1.55) than women not using anticholinergic drugs. In men, an association was found with decline in visual memory (OR, 1.63; 95% CI, 1.08-2.47) and to a lesser extent in executive function (OR, 1.47; 95% CI, 0.89-2.44). Notable interactions were observed in women between anticholinergic use and age, apolipoprotein E, or hormone therapy. A 1.4- to 2-fold higher risk of cognitive decline was observed for those who continuously used anticholinergic drugs but not for those who had discontinued use. The risk of incident dementia over the 4-year follow-up period was also increased in continuous users (hazard ratio [HR], 1.65; 95% CI, 1.00-2.73) but not in those who discontinued the use of anticholinergic drugs (HR, 1.28; 95% CI, 0.59-2.76). CONCLUSIONS: Elderly people taking anticholinergic drugs were at increased risk for cognitive decline and dementia. Discontinuing anticholinergic treatment was associated with a decreased risk. Physicians should carefully consider prescription of anticholinergic drugs in elderly people, especially in the very elderly and in persons at high genetic risk for cognitive disorder.
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00415864
Contributeur : Dominique Villebrun <>
Soumis le : mardi 27 juillet 2010 - 14:52:49
Dernière modification le : mercredi 11 octobre 2017 - 01:12:15
Document(s) archivé(s) le : jeudi 28 octobre 2010 - 11:12:53

Fichiers

Ancelin_Archives_of_internal_M...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Isabelle Carrière, Annie Fourrier-Reglat, Jean-François Dartigues, Olivier Rouaud, Florence Pasquier, et al.. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.: Anticholinergics and cognitive dysfunction. Archives of Internal Medicine, 2009, 169 (14), pp.1317-24. 〈10.1001/archinternmed.2009.229〉. 〈inserm-00415864〉

Partager

Métriques

Consultations de la notice

201

Téléchargements de fichiers

810